Adam Poussard is a Research Analyst at Janus Henderson Investors focused primarily on small- and mid-cap healthcare and technology stocks and is a member of the Health Care Sector Research Team. Prior to joining the firm in 2021, he held several analyst roles in a range of sectors, including healthcare and technology, at T. Rowe Price from 2010 before becoming an associate portfolio manager there in 2018 and then transitioning to senior investment analyst focused on industrials in early 2021. Before this, he was assistant vice president in equity research concentrating on healthcare distribution and technology companies at Barclays Capital (formerly Lehman Brothers) from 2006.
Adam received a bachelor of science degree in finance with a minor in economics from the University of Connecticut. He holds the Chartered Financial Analyst designation and has 17 years of financial industry experience.
You are now leaving janushenderson.com
You are now leaving our site and entering a website not operated by or affiliated with Janus Henderson Investors. While we aim to point you to useful external websites, we cannot be responsible for their content, opinions, advice or accuracy, even if you utilise the services on the linked site to invest in our products.
You should review the Terms and Conditions of third party websites and contact the operators of such sites if you have any queries.
You are now leaving Janus Henderson's website and will be redirected to the website of the Securities and Exchange Commission (the "SEC"). Money market funds are required to provide the SEC with a monthly electronic filing of more detailed portfolio holdings information on Form N-MFP.
Janus Henderson is not responsible for the content, accuracy or timeliness and does not make any warranties, express or implied, with regard to the information obtained from other websites. This link should not be construed as either a recommendation or offer to by or sell any securities.